Your browser doesn't support javascript.
loading
Improving power in PSA response analyses of metastatic castration-resistant prostate cancer trials.
Grayling, Michael J; McMenamin, Martina; Chandler, Robert; Heer, Rakesh; Wason, James M S.
Affiliation
  • Grayling MJ; Population Health Sciences Institute, Newcastle University, Baddiley-Clark Building, Richardson Road, Newcastle upon Tyne, NE2 4AX, UK. michael.grayling@newcastle.ac.uk.
  • McMenamin M; WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Special Administrative Region, China.
  • Chandler R; Northern Centre for Cancer Care, Newcastle upon Tyne, UK.
  • Heer R; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK.
  • Wason JMS; Department of Urology, Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
BMC Cancer ; 22(1): 111, 2022 Jan 26.
Article in En | MEDLINE | ID: mdl-35081926
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Monitoring / Prostatic Neoplasms, Castration-Resistant Limits: Humans / Male Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Monitoring / Prostatic Neoplasms, Castration-Resistant Limits: Humans / Male Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: